Contraceptive Technology Update – March 1, 2019
March 1, 2019
View Issues
-
Long-Acting Reversible Contraception: Progress Made, but Challenges Remain
In 2002, just 2.4% of U.S. women using birth control were using long-acting reversible contraceptive (LARC) methods, such as the intrauterine device or the contraceptive implant. By 2014, about 14% of women using birth control reported LARC use.
-
Quick Start for Teen Contraception: What’s Your Stance?
Family planning providers should develop ways to provide contraceptives to patients in one visit (known as Quick Start) for all methods, according to the Family Planning National Training Center’s Contraceptive Access Change Package. New research indicates that while most public-sector and private providers consider Quick Start for combined hormonal contraceptives and depot medroxyprogesterone acetate (DMPA) safe for use among adolescents, fewer private providers utilize the technique.
-
Research Focuses on Risk of Preterm Birth in Subsequent Pregnancy
In new research, investigators analyzed the risk of preterm birth among women with a previous poor pregnancy outcome. The results indicated that women had a higher chance of delivering before 32 weeks if their previous infant was born small for its gestational age. Those with a previous neonatal death were three times as likely to have a preterm birth subsequently, data indicated.
-
Are Women Getting Screened for Cervical Cancer?
-
Gabapentin May Offer Treatment Option for Vulvodynia
-
Consider Vaginal Estrogen for Genitourinary Syndrome of Menopause
-
New Report Makes Case to Act Against Skyrocketing STDs
A new review by the National Academy of Public Administration makes a convincing case to act against skyrocketing sexually transmitted disease rates.
-
Scientists Focus on Rapid Chlamydia Test
Just-released research findings indicate that a potential rapid chlamydia test delivers accurate results in about 30 minutes, which could make it possible for patients to be treated right away. Such point-of-care testing could help eliminate the need for follow-up appointments because patients would receive treatment at the time of diagnosis, say researchers.
-
In Memoriam: James Trussell, PhD